If a patient has a family history of MS, would you treat the patient with a TNF Blocker or switch to something else?

Featuring Benjamin Lockshin, MD |

EVP of Strategic Initiatives
Director of the Clinical Trials Center
Assistant Professor
US Dermatology Partners
Georgetown University
Rockville, MD

| Published April 15, 2022

View video transcript